SUMMARY
|
1
|
RISK
FACTORS
|
3
|
FORWARD-LOOKING
STATEMENTS
|
8
|
USE
OF PROCEEDS
|
9
|
DIVIDEND
POLICY
|
9
|
CAPITALIZATION
|
9
|
MANAGEMENT’S
DISCUSSION AND ANALYSIS OR PLAN OF OPERATIONS
|
10
|
BUSINESS
|
16
|
MANAGEMENT
|
24
|
SELLING
STOCKHOLDERS
|
32
|
PLAN
OF DISTRIBUTION
|
33
|
CERTAIN
RELATIONSHIPS AND RELATED PARTY TRANSACTIONS
|
34
|
PRINCIPAL
STOCKHOLDERS
|
37
|
MARKET
FOR COMMON EQUITY AND RELATED STOCKHOLDER MATTERS
|
38
|
DESCRIPTION
OF CAPITAL STOCK
|
39
|
DISCLOSURE
OF COMMISSION POSITION ON INDEMNIFICATION FOR SECURITIES ACT
VIOLATIONS
|
40
|
SHARES
ELIGIBLE FOR FUTURE SALE
|
41
|
LEGAL
MATTERS
|
41
|
EXPERTS
|
41
|
WHERE
YOU CAN FIND MORE INFORMATION
|
42
|
INDEX
TO FINANCIAL STATEMENTS
|
F-1
|
Common
stock offered by the selling stockholders
|
Up
to 34,444,517
shares
|
Terms
of the offering
|
The
selling stockholders will determine when and how they will sell the
common
stock offered by this prospectus. See “Plan of Distribution” for further
information on the terms of the offering.
|
Use
of Proceeds
|
We
will not receive any proceeds from the sale of stock by the selling
stockholders.
|
OTC
Bulletin Board Symbol
|
SPLX.OB
|
Three
Months
|
|||||||
Year
ended
|
Ended
|
||||||
Statement
of Operations Data
|
March
31, 2005
|
June
30, 2005
|
|||||
(Unaudited)
|
|||||||
Net
sales
|
$
|
49
|
$
|
70
|
|||
Net
loss
|
(3,296,189
|
)
|
(735,974
|
)
|
|||
Net
loss per basic and fully diluted share
|
(0.03
|
)
|
(0.01
|
)
|
|||
Pro
forma net loss (1)
|
(3,040,951
|
)
|
(735,974
|
)
|
|||
Pro
forma net loss per share (1)
|
$
|
(0.03
|
)
|
$
|
(0.01
|
)
|
|
Weighted
average shares outstanding
|
96,113,724
|
100,670,270
|
|||||
Consolidated
|
Consolidated
|
||||||
Balance
Sheet Data
|
At
March 31, 2005
|
At
6/30/2005
|
|||||
Cash
and cash equivalents
|
$
|
256,347
|
$
|
149,132
|
|||
Total
assets
|
452,918
|
315,133
|
|||||
Long
term liabilities
|
1,708,240
|
2,344,602
|
|||||
Stockholders'
equity (deficiency in assets)
|
(2,094,470
|
)
|
(2,830,444
|
)
|
|
•
|
|
new
companies or products entering our target
markets;
|
|
•
|
|
acceptance
and reliability of new products introduced by us or other
companies;
|
|
•
|
|
price
competition;
|
|
•
|
|
delays
in our introduction of new
products;
|
|
•
|
|
changes
in the mix of products and services available in our target
markets;
|
|
•
|
|
the
impact of changing technologies;
and
|
|
•
|
|
general
economic conditions.
|
|
•
|
|
our
perceived value in the securities
markets;
|
|
•
|
|
future
announcements concerning developments affecting our business or those
of
our competitors, including the receipt of substantial orders for
products;
|
|
•
|
|
overall
trends in the stock market;
|
|
•
|
|
the
impact of changes in our results of operations, our financial condition
or
our prospects on the perception of our company in the securities
markets;
|
|
•
|
|
changes
in recommendations of securities analysts;
and
|
|
•
|
|
sales
or purchases of substantial blocks of
stock.
|
|
•
|
|
be
time consuming and costly to
defend;
|
|
•
|
|
divert
management’s resources and
attention;
|
|
•
|
|
cause
product shipment delays;
|
|
•
|
|
require
us to redesign our products; or
|
|
•
|
|
require
us to enter into costly royalty or licensing
agreements.
|
|
•
|
|
changes
in, or impositions of, legislative or regulatory requirements regarding
our products or the technology upon which they are based, in both
the
United States and Russia;
|
|
|
•
|
|
delays
resulting from difficulties in obtaining export licenses for
technology;
|
|
•
|
|
experiencing
management communication difficulties due to distance, time differences
and international communication system
failures;
|
|
•
|
|
imposition
of tariffs, currency restrictions, quotas and other trade
barriers;
|
|
•
|
|
longer
product delivery cycles and decreased efficiency in communication
among
our development team;
|
|
•
|
|
increased
administrative expenses and legal costs;
and
|
|
•
|
|
other
occurrences beyond our control, including acts of terrorism, that
may
delay or prohibit efficient communication among our development
team.
|
|
•
|
|
dividend
rights and rates;
|
|
•
|
|
conversion
rights;
|
|
•
|
|
voting
rights;
|
|
•
|
|
terms
of redemption;
|
|
•
|
|
redemption
prices;
|
|
•
|
|
liquidation
preferences; and
|
|
•
|
|
the
number of shares constituting a series or the designation of such
series.
|
|
•
|
|
general
economic or political conditions in any of the major countries in
which we
do business;
|
|
•
|
|
delays
in development or shipment of our products or new versions of existing
products;
|
|
•
|
|
difficulties
in transitions to new business models or
markets;
|
|
•
|
|
introduction
of new products by existing and new
competitors;
|
|
•
|
|
difficulties
in implementing strategic
alliances;
|
|
•
|
|
difficulties
in establishing new distribution channels;
|
|
|
•
|
|
inability
to attract and retain key personnel;
|
|
•
|
|
lack
of market acceptance of new products, upgrades and
services;
|
|
•
|
|
changes
in demand for multi-dimensional solid and surface modeling
software;
|
|
•
|
|
intellectual
property disputes and litigation;
|
|
•
|
|
industry
transitions to new business models;
|
|
•
|
|
renegotiation
or termination of royalty or intellectual property licensing
arrangements;
|
|
•
|
|
changes
in accounting rules, such as expensing of stock options;
and
|
|
•
|
|
changes
in tax rates.
|
STOCKHOLDERS'
DEFICIENCY IN ASSETS
|
Unaudited
|
|||
Preferred
stock ($.001 par value, 150,000,000 shares
|
||||
authorized
and no shares issued and outstanding
|
$
|
—
|
||
Common
stock ($.001 par value, 300,000,000 shares
|
||||
authorized
and 100,670,270 shares issued and outstanding)
|
100,670
|
|||
Paid
in capital
|
1,101,049
|
|||
Deficit
accumulated during the development stage
|
(4,032,163
|
)
|
||
Total
stockholders' deficiency in assets
|
$
|
(2,830,444
|
)
|
·
|
Pairing
our products, and marketing, with leading providers of technical
computing
and imaging software.
We will seek to provide specialized software in marketing alliances
with
leading companies in order to build our name recognition and brand
loyalty. In June, 2005 we entered into a marketing and distribution
agreement with Waterloo Maple Inc. (“Maplesoft”), a leading provider of
technical computing software.
|
·
|
Targeting
organizations with a large number of employees who use software products
that can be effectively paired with our products.
We are developing our products for use by end-users in large collaborative
environments ranging from universities to for-profit corporations.
We
believe that it is possible to achieve sales to these customers and
organizations over the Internet based on targeted Internet-based
marketing
techniques that reach existing software product end-users by offering
them
sample/trial use of our products. Specifically, we will target
organizations that have a large number of employees using products
such as
AutoCAD®, Catia®, Mathematica®, MatLab®, Inventor®, SolidWorks® and other
products.
|
·
|
Embedding
our software.
We intend to pursue opportunities to license our software and technology
in software applications whose users can benefit from improved
visualization capabilities. We believe that embedding our software
in such
a manner will also help establish our brand name. To date, we have
no
formal licensing agreement with any
company.
|
·
|
Continuing
to invest in research and development.
We intend to continue to invest in research and development in order
to
develop our products. As of June 1,
2005,
90% of our full and part-time employees and independent contractors
were
engaged in research and development activities. In addition, we maintain
close ties with numerous leading technical universities in Russia
which
provides us with access to the latest research into new
technologies.
|
·
|
Protecting
intellectual property rights.
We believe our software is superior in part because it is based on
unique
problem-solving algorithms and mathematical procedures. We will pursue
new
patent filings as our research team develops patentable processes.
We also
intend to apply for patent protection on a country-by-country basis
as
needed to protect our intellectual property rights if we decide to
pursue
sales outside of North America. In addition, we will copyright our
software where possible and take measures we believe are appropriate
and
commercially reasonable to protect our trade
secrets.
|
·
|
Software
programming based on open industry standards.
We will adhere to industry standards such as OpenGL throughout our
product
line. We believe that adherence to open standards will strengthen
our
market position because our prospective customers prefer products
that
conform to open standards.
|
·
|
providing
direct sample/limited trial offers and sales through direct mail
campaigns
and over the Internet;
|
·
|
through
search engine and similar key word technology on the
Internet;
|
·
|
distributing
trial and sample versions of our programs at seminars and industry
events;
|
·
|
buying
sponsored search links, such as AdWords offered by Google, Inc.,
and
banner advertising on the Internet;
|
·
|
entering
into alliances with other software
companies;
|
·
|
through
dealers, distributors and third-party sales representatives;
and
|
·
|
end-users:
educational and commercial creators of sophisticated computational
and
analytic model, and end-users of digital content creation and 3D
information management software;
and
|
·
|
original
equipment manufacturers or “OEMs”, and software vendors: businesses that
bundle software with image capture devices such as laser radar scanners,
and software vendors who provide 3D information management software
to
businesses and bundle third-party
software.
|
·
|
engineers,
architects and mechanical and civil engineering designers that use
computer aided design, or “CAD” and computer aided manufacturing, or
“CAM”, software;
|
·
|
biometrics
and forensics professionals;
|
·
|
digital
artists such as animators, graphic designers, web designers, videographers
and photographers;
|
·
|
medical
imaging specialists;
|
·
|
geographers,
aerial and satellite image processing specialists, geologists and
other
workers in the earth and environmental sciences (use of digital imaging
in
these fields is known as
“geomatics”);
|
·
|
national
security and military applications professionals and contractors;
and
|
·
|
mathematics,
science and engineering educational institutions and
students.
|
·
|
Medical
imaging.
Medical imaging generally involves the use of advanced electromagnetic,
ultrasonic and radiological imaging devices for scanning internal
structures in human bodies. Magnetic resonance imaging, or “MRI”, is one
of the most complex and one of the fastest-growing forms of diagnostic
imaging. Software associated with MRI devices is used to create graphical
representations of scan data in order to assess existing medical
conditions. The key technical challenge for medical imaging is to
visualize, accurately and in near-real time, image features that
indicate
pathology or disease. We believe our technology will be of value
in
medical imaging because it allows the user to manage larger amounts
of
data than other technologies and subsequently remove redundant data
points
from relatively large data files with over 5 gigabytes (a “gigabyte or
“GB” is a measure of computer data storage capacity). We believe that
these two capabilities will help generate enhanced visual images
to be
used by trained medical personal with personal computers to assess
findings and make more accurate and timely
diagnoses.
|
·
|
Geomatics
imaging.
Geomatics is the science of measurement, analysis, management, storage
and
display of Earth-related data in digital form. Geomatics imaging
generally
involves the use of imaging from satellites and radar devices to
scan
existing topographic, atmospheric or subsurface conditions. In simple
terms, geomatics is a digital method for creating highly detailed
and
accurate maps. The key technical challenge is to transform, accurately
and
in near-real time, large data files containing over 100GB of data
into
accurate visual scenes. This must be done accurately (to the nearest
centimeter in some cases) and in near-real time and may require the
fusing
of these images with existing topological data. The goal is to use
personal computers to identify target objects or make data comparisons
against existing geomatics data sets. Visual images highlighting
differences (using false color to emphasize differences, as an example)
can be generated for use by a trained geomatics specialist or
non-professional.
|
·
|
Terrestrial
imaging.
Terrestrial imaging generally involves the use of advanced optical
and
laser radar devices to scan existing structures such as buildings,
bridges
and roads. The key technical challenge is to obtain and process large
data
files that may combine photographic and radar images. This processing
needs to occur in near-real time and be accurate to the nearest
millimeter. The files typically contain over 10GB of data. Scanned
data
are commonly transformed into visual scenes that professionals with
CAD-capable personal computers can use in the field to rapidly find
target
objects or make dimensional comparisons among data
sets.
|
·
|
Metrological
imaging.
Metrology is the science of measurement. It includes the field of
biometrics, or measuring human dimensional characteristics. Imaging
for
metrology generally involves the use of advanced optical and laser
radar
scanner devices combined with calibrated high resolution digital
photographic images which are referred to as photogrametric images.
For
example, the contour of the upper part of a human face measured with
a
high degree of precision can be reliably used for biometric identification
of individuals. The key technical challenge is to transform, accurately
and in real time, relatively small data files into visual scenes
that are
accurate to the nearest micron. The goal is to allow professionals
in the
field using personal computers to make rapid data comparisons against
existing mechanical drawings or existing stored biometric data. Aircraft,
automotive and heavy equipment manufacturers, for example, use
metrological imaging to determine if finished components deviate
from
design specifications.
|
·
|
Entertainment
imaging.
The use of computer generated original images and objects such as
backgrounds, characters and special effects, as well as scanned data
to
assist in digitally re-creating locations, continues to grow in the
film,
commercial, corporate and computer gaming markets. These markets
are
typically characterized by a constant need to provide higher quality
and
more realistic images to meet consumers’ growing demand. One example is
the use of optical motion capture products which track and record
performances of people while they move on a stage and whose data
is then
converted for use with digital characters in computer games to make
the
player movements more realistic.
|
·
|
Seismic
and sonar scan arrays imaging.
Geologists, civil engineers and earth scientists use seismic and
sonar
data for oil and mineral exploration and for fundamental geophysical
research. The technical challenge is to process 3D image data sets
into
usable forms for use with personal computers more quickly and
cost-effectively than is currently
possible.
|
·
|
National
security & military imaging.
National security imaging generally involves the use of advanced
optical
and laser radar devices to accurately determine existing shapes for
mechanical or biometric conditions. The key technical challenge is
to
transform, accurately and in real time, relatively small data files
typically containing less than 1GB of data into visual scenes accurate
to
the nearest micron. The primary objective in biometric and surveillance
imaging is to rapidly assess whether objects in the scanned scene
represent a threat. Ideally this would be accomplished by using personal
computers or desktop computers. This task involves identification
of
target objects, conditions or people by making comparisons against
stored
data sets. Portal and facility surveillance and cargo container inspection
are examples of national security
imaging.
|
·
|
the
ability to continue to create innovative and relevant technology;
|
·
|
the
quality and breadth of product and service
offerings;
|
·
|
the
ease and speed with which a product can be integrated with existing
customers’ software and systems, embedded in semiconductors, integrated
with a manufacturer’s existing internal systems and deployed to
end-users;
|
·
|
whether
the software operates efficiently within numerous
environments;
|
·
|
financial
resources;
|
·
|
price;
|
·
|
time
to market; and
|
·
|
effectiveness
of sales and marketing efforts.
|
Name
|
Age
|
Position
|
Director
or
Officer
Since
|
|||
Michael
Stojda
|
41
|
Director,
President and Chief Executive Officer
|
2004
|
|||
Kevin
Fitzgerald
|
48
|
Chairman
of the Board
|
2004
|
|||
Dr.
Peter Novak
|
52
|
Director
|
2004
|
|||
Edward
Dubrovsky
|
31
|
Director
|
2004
|
|||
Alexander
Yarmolinsky
|
31
|
Director
|
2005
|
|||
Curtis
Wolfe
|
42
|
General
Counsel, Secretary and Director
|
2004
|
|||
Gerard
Herlihy
|
52
|
Chief
Financial Officer
|
2004
|
|||
Christian
Schormann
|
40
|
Vice
President Research & Development
|
2005
|
·
|
Selecting
and hiring our independent
auditors.
|
·
|
Evaluating
the qualifications, independence and performance of our independent
auditors.
|
·
|
Approving
the audit and non-audit services to be performed by our independent
auditors.
|
·
|
Reviewing
the design, implementation, adequacy and effectiveness of our internal
controls and our critical accounting
policies.
|
·
|
Overseeing
and monitoring the integrity of our financial statements and our
compliance with legal and regulatory requirements as they relate
to
financial statements or accounting
matters.
|
·
|
Reviewing
with management and our auditors any earnings announcements and other
public announcements regarding our results of
operations.
|
·
|
Preparing
the audit committee report we are required to include in filings
with the
Commission.
|
•
|
|
personal
and professional integrity, ethics and
values;
|
•
|
|
experience
in corporate management, and a general understanding of marketing,
finance
and other elements relevant to the success of a publicly-traded company
in
today’s business environment;
|
•
|
|
experience
in the computer industry in general, and the graphics and computational
software industry in particular;
|
•
|
|
experience
as a board member of another publicly-held company;
and
|
•
|
|
practical
and mature business judgment, including the ability to make independent
analytical inquiries.
|
Long
Term Compensation
|
|||||||||||||||||||
Annual
Compensation
|
Awards
|
||||||||||||||||||
Name
and Principal Position
|
Fiscal
Year
|
Salary
($)
|
Bonus
($)
|
Other
($)
|
Restricted
Stock
Awards
($)
|
Securities
Underlying
Options/
SAR’s
(#)
|
|||||||||||||
Michael
Stojda -
Director,
President and
Chief
Executive Officer (1)
|
2005
|
$
|
156,561
|
$
|
—
|
$
|
—
|
$
|
12,000
(2
|
)
|
400,000
|
||||||||
Christian
Schormann -
Vice
President,
Research
and Development (3)
|
2005
|
$
|
38,730
|
$
|
—
|
$
|
—
|
$
|
7,500
(4
|
)
|
250,000
|
||||||||
Gerard
Herlihy -
Chief
Financial Officer (5)
|
2005
|
$
|
91,116
|
$
|
—
|
$
|
—
|
$
|
—
|
—
|
(1)
|
Mr. Stojda
joined us September 1, 2004. Mr. Stojda’s base salary is $275,000 per
year, and he is eligible to earn an annual bonus of up to 100% of
his base
salary.
|
(2)
|
Mr.
Stojda received, under the terms of his employment agreement,
400,000 shares of restricted common
stock that are
subject to a lapsing right of forfeiture.
The
right of
forfeiture lapsed with
respect to 233,333 shares
as
of March 31, 2005 and
the
remaining shares lapse at the rate of 33,333
shares per month until fully lapsed.
No cash consideration was paid for these restricted shares.
|
(3)
|
Mr.
Schormann joined us on January 12, 2005. His base salary is $190,000
per
year, and he is eligible to earn an annual bonus of up to 25% of
his base
salary.
|
(4)
|
Mr.
Schormann receive, under the terms of his employment agreement, 250,000
shares of restricted common stock that are subject to a lapsing right
of
forfeiture, which right will lapse with respect to 62,500 of the
restricted shares on January 25, 2006 and at a rate of 5,208 shares
per
month thereafter.
|
(5)
|
Mr.
Herlihy joined us on June 1, 2004. His base salary is $110,000 per
year,
and he is eligible to receive an annual performance bonus of up to
50% of
his base salary.
|
Name
|
Number
of Securities Underlying
Options/SARs
Granted (#)
|
%
of Total Options/SARs Granted
to
Employees in Fiscal Year
|
Exercise
or
Base
Price ($/S)
|
Expiration
Date
|
|||||||||
Michael
Stojda
|
2,000,000
(1
|
)
|
31.4
|
%
|
$
|
0.20
|
9/1/2014
|
||||||
Michael
Stojda
|
1,500,000
(2
|
)
|
23.5
|
%
|
$
|
0.50
|
9/1/2014
|
||||||
Christian
Schormann
|
1,000,000(3
|
)
|
15.7
|
%
|
$
|
0.20
|
1/12/2015
|
1.
|
On January 18, 2005, pursuant to an employment agreement dated September 1, 2004, we granted to Mr. Stojda an option to purchase 2,000,000 shares of common stock under the Stock Option Plan. These options have an exercise price of $0.20 per share. As of March 31, 2005, this option was vested with respect to 388,888 shares, and the remaining shares vest at a rate of 55,555 per month over the following 29 months. |
2.
|
On January 18, 2005, pursuant to an employment agreement dated September 1, 2004, we granted to Mr. Stojda an option to purchase 1,500,000 shares of our common stock. This option was not granted under the 2004 Stock Option Plan and has an exercise price of $0.50 per share. This option will be fully vested upon the first to occur of (1) the date that the cumulative revenues of the Company exceed $50,000,000 or (2) September 1, 2009. |
3.
|
On January 25, 2005, pursuant to an employment agreement dated January 12, 2005, we granted to Mr. Schormann, an option to purchase 1,000,000 shares of our common stock. This option was granted under the 2004 Stock Option Plan and has an exercise price of $0.20 per share. On January 12, 2006, this option will vest with respect to 250,000 shares. The option will vest with respect to an additional 20,833 shares per month commencing February 12, 2005. |
Name
|
Shares
acquired on Exercise (#)
|
Value
realized
|
Number
of Securities Underlying Unexercised Options/SARs at FY-End
(#)
Exercisable/
Non
Exercisable
|
Value
of Unexercised In-the-Money Options/SARs at FY-End ($)
Exercisable/
Non
Exercisable
|
|||||||||
Michael
Stojda
|
—
|
$
|
—
|
388,888/3,111,112
|
$
|
—
|
|||||||
Christian
Schormann
|
—
|
$
|
—
|
0/1,500,000
|
$
|
—
|
o
|
if
any “person” (as defined in Sections 13(d)(3) and 14(d)(3) of the
Exchange Act), other than us, our subsidiary, a compensation plan
of ours
or of our subsidiary or any person reported as a beneficial owner
of our
common stock in this prospectus, becomes the “beneficial owner” (as
defined Rule 13d-3 of the Exchange Act) of thirty percent
(30%) or
more of our outstanding common
stock;
|
o
|
if
there is a change in composition of our board within a two year period
as
a result of which a majority of our directors are individuals who
were not
either (1) directors as of September 1, 2004 or (2)
elected,
nominated for election or individuals whose election was confirmed
by, at
least a two-thirds majority of the Board;
or
|
o
|
if
our stockholders approve (1) a sale, reorganization, merger or
consolidation with respect to which persons who were our stockholders
immediately prior to such transaction do not own securities representing
more than fifty percent of the voting power entitled to elect directors
of
the surviving entity immediately after the transaction; (2) our
liquidation or dissolution or (3) the sale of all or substantially
all of
our assets.
|
o
|
Mr. Stojda’s
continued, willful and deliberate failure to perform his
duties;
|
o
|
Mr. Stojda
engages in misconduct materially and demonstrably injurious to us;
or
|
o
|
Mr. Stojda
is convicted of a felony.
|
o
|
a
Change in Control;
|
o
|
a
reduction of Mr. Stojda’s duties, title, reporting status or
responsibilities;
|
o
|
a
reduction of Mr. Stojda’s
salary;
|
o
|
relocation
of our principal place of business after Mr. Stojda relocates
to
south Florida; or
|
o
|
our
material breach of the employment
agreement.
|
·
|
250,000
shares of our common stock that shall be subject to a lapsing right
of
forfeiture which right shall lapse with respect to 62,500 of the
restricted shares on the first anniversary of the date of his employment
and at a rate of 5,208 shares per month after such date.
|
·
|
An
option to purchase 1,000,000 shares of common stock with an exercise
price
of $.20 per share, which shall vest and become exercisable with respect
to
250,000 shares on the first anniversary of the date of his employment,
and
at a rate of 20,833 shares per month after such date.
|
·
|
If
we have not commenced development and committed funding of a specified
research and development project by the first anniversary of the
date of
his employment, we will grant Mr. Schormann an option to purchase
750,000
shares of common stock with an exercise price per share equal to
the fair
market value on the date of grant. This option shall vest in three
equal
installments beginning on the first anniversary of the date of
grant.
|
·
|
Any
change in control of our company, including a merger or consolidation
with
any other entity in which we are not the surviving corporation or
in any
transaction in which persons who are not a majority of our stockholders
prior to such transaction acquire the power to appoint a majority
of our
directors; including
any “person” (as such term is defined in Sections 13(d)(3) and
Section 14(d)(3) of the Exchange Act) other than Splinex,
a
majority-owned subsidiary of Splinex or a compensation plan of Splinex
or
of a majority-owned subsidiary of Splinex, becomes the “beneficial owner”
(as such term is defined in Rule 13d-3 of the Exchange Act),
directly
or indirectly, of our securities representing 50% or more of the
combined
voting power of our company; or
|
·
|
our
stockholders approve (1) a sale or merger with respect to
which our
stockholders immediately prior to such sale or merger do not immediately
after such sale or merger own more than 50% of the combined voting
power
entitled to vote generally in the election of the directors of the
sold,
reorganized, merged or consolidated entity, and such sale or merger
is
consummated; (2) a liquidation or dissolution of our company;
or
(3) the sale of all or substantially all of our assets.
|
Shares
Beneficially Owned
|
Common
Stock
|
Shares
Beneficially Owned
|
||||||||||||||||
|
Prior
to the
Offering
|
Offered
|
After
the Offering
|
|||||||||||||||
Name
of Selling Stockholders
|
Number
|
Percent
|
Number
|
Number
|
Percent
|
|||||||||||||
Splinex,
LLC(1)
|
95,000,000
|
94.4
|
%
|
30,000,000
|
65,000,000
|
64.6
|
%
|
|||||||||||
Ener1
Group, Inc.(2)
|
4,414,054
|
(2)
|
|
4.4
|
%
|
4,414,054
|
0
|
*
|
||||||||||
Kevin
Fitzgerald
|
4,276
|
(2)
|
*
|
4,276
|
0
|
*
|
||||||||||||
Peter
Novak
|
26,187
|
(2)
|
|
*
|
26,187
|
0
|
(3)
|
|
*
|
*
|
|
Indicates
ownership of less than 1%.
|
(1)
|
|
Dr. Peter
Novak, Mike Zoi, Ludmila Enilina and Albina Boeckli have dispositive
and
voting power over the shares of our common stock held by Splinex,
LLC.
|
(2)
|
|
Dispositive
and voting power over the shares of our common stock that will be
held by
Ener1 Group is exercised by the board of directors of Ener1 Group,
which
consists of Dr. Peter Novak, Mike Zoi and Boris
Zingarevich.
|
(3)
|
|
Amount
shown excludes shares owned indirectly through Splinex, LLC, of which
Dr. Novak is a member and through Ener1 Group, Inc., of which
an
entity owned by Dr. Novak is a
stockholder.
|
•
|
|
the
name of each such selling stockholder and of the participating
broker-dealer(s);
|
•
|
|
the
number of shares involved;
|
•
|
|
the
price at which such shares were
sold;
|
•
|
|
the
commissions paid or discounts or concessions allowed to such
broker-dealer(s), where applicable;
|
•
|
|
that
such broker-dealer(s) did not conduct any investigation to verify
the
information set out or incorporated by reference in this prospectus;
and
|
•
|
|
other
facts material to the transaction.
|
|
|
|
|
|
|
|
|
|
|
|
Splinex,
LLC
|
|
|||||
|
|
Ownership
Interest
|
|
Relationship
With
|
||||
Name
|
|
(voting/economic)
|
|
Ener1
Group
|
|
Ener1,
Inc.
|
|
Splinex
Technology Inc.
|
Alexander
Malovik
|
|
50%/49%
|
|
None
|
|
None
|
|
Indirect
Stockholder Owned 100% of ANTAO Ltd, which he contributed to Splinex
Technology pursuant to his obligations under the Splinex, LLC operating
agreement
|
|
|
|
|
|
|
|
|
|
Boris
Zingarevich
|
|
12.5%/12.75%
|
|
Indirect
Stockholder,
Director
|
|
Indirect
Stockholder
|
|
Indirect
Stockholder and Beneficial owner of Bzinfin, which has entered into
the
Revolving Loan Agreement with Splinex Technology
|
|
|
|
|
|
|
|
|
|
Mikhail
Zingarevich
|
|
12.5%/12.75%
|
|
Brother
of Boris Zingarevich
|
|
Brother
of Boris Zingarevich
|
|
Indirect
Stockholder
|
|
|
|
|
|
|
|
|
|
Peter
Novak
|
|
12.5%/12.75%
|
|
Chief
Technology
Officer,
Indirect
Stockholder,
Director
|
|
Consultant,
Director,
Indirect
Stockholder
|
|
Consultant,
Director,
Indirect
Stockholder
|
|
|
|
|
|
|
|
|
|
Mike
Zoi
|
|
12.5%/12.75%
|
|
President,
Indirect
Stockholder,
Director
|
|
Consultant,
Director,
Indirect
Stockholder
|
|
Consultant,
Indirect
Stockholder
|
|
|
|
|
|
|
|
|
|
Kevin
Fitzgerald
|
|
None
|
|
None
|
|
Chairman,
Chief
Executive
Officer,
Stockholder
|
|
Chairman
|
Curtis
Wolfe
|
|
None
|
|
General
Counsel and Secretary
|
|
None
|
|
Director,
General Counsel and Secretary
|
•
|
|
each
person of whom we are aware that beneficially owns more than 5% of
our
common stock;
|
•
|
|
each
of the directors and named executive officers individually;
and
|
•
|
|
all
directors and executive officers as a
group.
|
Name
and Address of Beneficial Owner
|
Amount
and Nature of
Beneficial Owner (number of common shares) |
Percent
of Class |
||
Splinex,
LLC(1)
|
95,000,000
|
94.4%
|
||
Kevin
Fitzgerald
|
4,276
|
*
|
||
Michael
Stojda (2)
|
1,122,222
|
1.1%
|
||
Peter
Novak (3)
|
26,187
|
*
|
||
Edward
Dubrovsky
|
1,194
|
*
|
||
Alexander
Yarmolinsky
|
120
|
*
|
||
Curtis
Wolfe (4)
|
93,750
|
*
|
||
Gerard
Herlihy (5)
|
112,500
|
*
|
||
Christian
Schormann
|
250,000
|
*
|
||
All
named executive officers and directors as a group (8
persons)
|
1,610,249
|
1.6%
|
(1)
|
Dr. Peter
Novak, Mike Zoi, Ludmila Enilina and Albina Boeckli have dispositive
and
voting power over the shares of our common stock held by Splinex,
LLC.
|
(2)
|
Includes
options to purchase 111,111 shares of common stock which could be
acquired
within 60 days of July 31, 2005 and 66,666 shares of restricted stock,
the
restrictions as to which will lapse within 60 days of July 31,
2005.
|
(3)
|
Amount
shown excludes shares owned indirectly through Splinex, LLC, of which
Dr. Novak is a member and owned indirectly through Ener1 Group,
Inc.,
of which an entity owned by Dr. Novak is a
stockholder.
|
(4)
|
Includes
options to purchase 31,250 shares of common stock which could be
acquired
within 60 days of July 31, 2005.
|
(5)
|
Includes
options to purchase 37,500 shares of common stock which could be
acquired
within 60 days of July 31, 2005.
|
(6)
|
Represents
shares of restricted stock, the restrictions as to which will begin
lapsing in January 2006.
|
High
|
Low
|
||||||
Period
from July 21, 2005 through August 19, 2005
|
$
|
0.50
|
$
|
0.05
|
Plan
Category
|
Number
of Securities to be Issued Upon Exercise of Outstanding Options,
Warrants
and Rights
|
Weighted-average
exercise price of outstanding options, warrants and rights
|
Number
of securities remaining available for future issuance under equity
compensation plans (excluding securities reflected in the first
column)
|
|||||||
Equity
compensation plans approved by security holders.
|
4,825,000
|
$
|
0.16
|
5,175,000
|
||||||
Equity
compensation plans not approved by security holders
|
1,500,000
|
$
|
0.50
|
NA
|
•
|
|
for
a violation of a criminal law unless the director, officer, employee
or
agent had reasonable cause to believe his or her conduct was lawful
or had
reasonable cause to believe his or her conduct was
unlawful;
|
•
|
|
for
acts or omissions not in good faith or which involve willful misconduct
or
a conscious disregard for the best interests of the corporation;
or
|
•
|
|
for
any transaction from which the director derives an improper personal
benefit.
|
•
|
|
a
majority vote of the quorum of our board of directors excluding those
directors who were or are parties to the
proceeding;
|
•
|
|
by
a committee duly designated by our board of directors consisting
of two or
more directors excluding those directors who are or were parties
to the
proceeding;
|
•
|
|
by
independent legal counsel; or
|
•
|
|
by
the majority vote of a quorum of stockholders who were not parties
to the
proceeding, or by a majority vote of stockholders who were not parties
to
the proceeding.
|
Attn.:
Secretary
|
550
West Cypress Creek Road
|
Suite 410
|
Fort
Lauderdale, Florida 33309 U.S.A.
|
|
Page
|
|||
Financial
Statements
|
|
|||
Report
of Independent Registered Public Accounting Firm
|
F-2
|
|||
Balance
Sheets as of March 31, 2005 and June 30, 2005
(Unaudited)
|
F-4
|
|||
Statements
of Operations for the period from inception (October 28, 2003)
through March 31, 2004, for the year ended March 31, 2005,
for the
three months ended June 30, 2005 (Unaudited) and for the period from
inception (October 28, 2003) through June 30, 2005
(Unaudited)
|
F-5
|
|||
Statements
of Changes in Stockholders’ Equity (Deficiency in Assets) for the period
from inception (October 28, 2003) through March 31,
2004, for
the year ended March 31, 2005, and for the three months ended June
30,
2005 (Unaudited)
|
F-6
|
|||
Statements
of Cash Flows for the period from inception (October 28, 2003)
through March 31, 2004, for the year ended March 31, 2005,
for the
three months ended June 30, 2005, and for the period from inception
(October 28, 2003) through June 30, 2005 (Unaudited)
|
F-7
|
|||
Notes
to Financial Statements
|
F-8
|
Jeffrey
A. Bolton, C.P.A., P.A.
Timothy
R. Devlin, C.P.A., P.A.
Michael
S. Kridel, C.P.A., P.A.
Marjorie
A. Horwin, C.P.A., P.A.
Patrick
D. Heyn, C.P.A., P.A.
Gary
R. McConnell, C.P.A., P.A.
Colleen
DeWoody Bracci, C.P.A.
Arthur
J. Hurley, C.P.A.
|
||
REPORT
OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM
|
March
31, 2005
|
June
30, 2005
|
||||||
ASSETS
|
(Unaudited)
|
||||||
Current
assets
|
|||||||
Cash
|
$
|
256,347
|
$
|
149,132
|
|||
Prepaid
expenses and other
|
76,119
|
60,894
|
|||||
Loans
and advances to employees - current portion
|
13,834
|
14,684
|
|||||
Total
current assets
|
346,300
|
224,710
|
|||||
Property
and equipment, net
|
49,862
|
43,246
|
|||||
Accounting
software license
|
37,000
|
31,969
|
|||||
Other
assets
|
9,881
|
9,881
|
|||||
Loans
to employees - long term portion
|
9,875
|
5,327
|
|||||
Total
assets
|
$
|
452,918
|
$
|
315,133
|
|||
LIABILITIES
AND STOCKHOLDERS' DEFICIENCY IN ASSETS
|
|||||||
Current
liabilities
|
|||||||
Accounts
payable
|
434,967
|
389,323
|
|||||
Accrued
expenses
|
221,572
|
276,027
|
|||||
Due
to related parties
|
106,760
|
79,726
|
|||||
Other
current liabilities
|
75,849
|
55,899
|
|||||
Total
current liabilities
|
839,148
|
800,975
|
|||||
Long
term liabilities
|
|||||||
Note
payable and accrued interest - related party
|
1,708,240
|
2,344,602
|
|||||
Total
liabilities
|
2,547,388
|
3,145,577
|
|||||
COMMITMENTS
AND CONTINGENCIES
|
|||||||
STOCKHOLDERS'
DEFICIENCY IN ASSETS
|
|||||||
Preferred
stock ($.001 par value, 150,000,000 shares
|
|||||||
authorized
and no shares issued and outstanding
|
-
|
-
|
|||||
Common
stock ($.001 par value, 300,000,000 shares
|
|||||||
authorized
and 100,670,270 shares issued and outstanding)
|
100,670
|
100,670
|
|||||
Paid
in capital
|
1,101,049
|
1,101,049
|
|||||
Deficit
accumulated during the development stage
|
(3,296,189
|
)
|
(4,032,163
|
)
|
|||
Total
stockholders' deficiency in assets
|
(2,094,470
|
)
|
(2,830,444
|
)
|
|||
Total
liabilities and stockholders' deficiency in assets
|
$
|
452,918
|
$
|
315,133
|
|||
Cumulative
|
|||||||||||||
From
Inception
|
From
Inception
|
||||||||||||
(October
28,
|
(October
28,
|
||||||||||||
2003)
|
Year
|
Three
Months
|
2003)
|
||||||||||
through
|
Ended
|
Ended
|
Through
|
||||||||||
March
31, 2004
|
March
31, 2005
|
June
30, 2005
|
June
30, 2005
|
||||||||||
(Unaudited)
|
(Unaudited)
|
||||||||||||
Net
sales
|
$
|
-
|
$
|
49
|
$
|
70
|
119
|
||||||
Operating
Expenses
|
|||||||||||||
Sales
and marketing
|
-
|
365,278
|
140,168
|
505,446
|
|||||||||
General
and administrative
|
709,047
|
1,196,859
|
269,499
|
2,175,405
|
|||||||||
Research
and development
|
113,800
|
1,208,722
|
301,189
|
1,623,711
|
|||||||||
Total
operating expenses
|
822,847
|
2,770,859
|
710,856
|
4,304,562
|
|||||||||
Costs
of merger and registration
|
-
|
512,321
|
-
|
512,321
|
|||||||||
Total
expenses
|
822,847
|
3,283,180
|
710,856
|
4,816,883
|
|||||||||
Loss
from operations
|
(822,847
|
)
|
(3,283,131
|
)
|
(710,786
|
)
|
(4,816,764
|
)
|
|||||
Interest
expense, net
|
-
|
(13,058
|
)
|
(25,188
|
)
|
(38,246
|
)
|
||||||
Loss
before income taxes
|
(822,847
|
)
|
(3,296,189
|
)
|
(735,974
|
)
|
(4,855,010
|
)
|
|||||
Income
taxes
|
-
|
-
|
-
|
-
|
|||||||||
Net
loss
|
$
|
(822,847
|
)
|
$
|
(3,296,189
|
)
|
$
|
(735,974
|
)
|
$
|
(4,855,010
|
)
|
|
Net
loss per basic and fully diluted share
|
$
|
(0.01
|
)
|
$
|
(0.03
|
)
|
$
|
(0.01
|
)
|
$
|
(0.05
|
)
|
|
Weighted
average shares outstanding
|
95,000,000
|
96,113,724
|
100,670,270
|
96,656,126
|
Deficit
|
||||||||||||||||||||||
Accumulated
|
Total
|
|||||||||||||||||||||
Additional
|
During
the
|
Stockholders'
|
||||||||||||||||||||
Preferred
Stock
|
Common
Stock
|
Paid
in
|
Development
|
Deficiency
|
||||||||||||||||||
Shares
|
Amount
|
Shares
|
Amount
|
Capital
|
Stage
|
in
Assets
|
||||||||||||||||
Common
stock issued $0.001 per share
|
||||||||||||||||||||||
effective
at inception on October 28, 2003
|
-
|
-
|
95,000,000
|
$
|
95,000
|
$
|
(94,999
|
)
|
$
|
-
|
$
|
1
|
||||||||||
Additional
capital contributed during period
|
-
|
-
|
849,999
|
-
|
849,999
|
|||||||||||||||||
Net
loss (see Note 4)
|
-
|
-
|
-
|
-
|
(822,847
|
)
|
-
|
(822,847
|
)
|
|||||||||||||
Balance
at March 31, 2004
|
-
|
-
|
95,000,000
|
95,000
|
(67,847
|
)
|
-
|
27,153
|
||||||||||||||
Additional
capital contributed during period
|
-
|
-
|
-
|
-
|
1,150,000
|
-
|
1,150,000
|
|||||||||||||||
Shares
issued as executive compensation
|
||||||||||||||||||||||
and
other expenses
|
-
|
-
|
670,270
|
670
|
23,896
|
-
|
24,566
|
|||||||||||||||
Shares
issued in Merger
|
-
|
-
|
5,000,000
|
5,000
|
(5,000
|
)
|
-
|
-
|
||||||||||||||
Net
loss
|
-
|
-
|
-
|
-
|
-
|
(3,296,189
|
)
|
(3,296,189
|
)
|
|||||||||||||
Balance
at March 31, 2005
|
-
|
-
|
100,670,270
|
|
100,670
|
|
1,101,049
|
|
(3,296,189
|
)
|
|
(2,094,470
|
)
|
|||||||||
Net
loss
|
-
|
-
|
-
|
-
|
-
|
(735,974
|
)
|
(735,974
|
)
|
|||||||||||||
Balance
at June 30, 2005 (unaudited)
|
|
-
|
$
|
-
|
|
100,670,270
|
$
|
100,670
|
$
|
1,101,049
|
$
|
(4,032,163
|
)
|
$
|
(2,830,444
|
)
|
Cumulative
|
|||||||||||||
From
Inception
|
From
Inception
|
||||||||||||
(October
28,
|
(October
28,
|
||||||||||||
2003)
|
Year
|
Three
Months
|
2003)
|
||||||||||
Through
|
Ended
|
Ended
|
Through
|
||||||||||
March
31, 2004
|
March
31, 2005
|
June
30, 2005
|
June
30, 2005
|
||||||||||
(Unaudited)
|
(Unaudited)
|
||||||||||||
Cash
flows from operating activities:
|
|||||||||||||
Net
loss
|
$
|
(822,847
|
)
|
$
|
(3,296,189
|
)
|
$
|
(735,974
|
)
|
$
|
(4,855,010
|
)
|
|
Adjustments
to reconcile net loss to net
|
|||||||||||||
cash
used in operating activities:
|
|||||||||||||
Depreciation
|
5,493
|
24,075
|
6,616
|
36,184
|
|||||||||
Executive
compensation and other expenses
|
|||||||||||||
paid
with common stock
|
-
|
24,566
|
-
|
24,566
|
|||||||||
Non
cash interest expense
|
-
|
8,240
|
25,119
|
33,359
|
|||||||||
Changes
in operating assets and liabilities:
|
-
|
||||||||||||
Prepaid
expenses and other
|
(6,112
|
)
|
(31,158
|
)
|
306
|
(36,964
|
)
|
||||||
Due
to related parties
|
-
|
106,759
|
(27,034
|
)
|
79,725
|
||||||||
Other
assets
|
(9,881
|
)
|
-
|
-
|
(9,881
|
)
|
|||||||
Accounts
payable
|
58,498
|
376,469
|
(45,644
|
)
|
389,323
|
||||||||
Accrued
expenses
|
149,041
|
72,531
|
54,455
|
276,027
|
|||||||||
Total
adjustments
|
197,039
|
581,482
|
13,818
|
792,339
|
|||||||||
Net
cash used in operating activities
|
(625,808
|
)
|
(2,714,707
|
)
|
(722,156
|
)
|
(4,062,671
|
)
|
|||||
Cash
flows from investing activities:
|
|||||||||||||
Purchase
of equipment
|
(55,229
|
)
|
(24,200
|
)
|
-
|
(79,429
|
)
|
||||||
Employee
loans and advances, net
|
(3,550
|
)
|
(20,159
|
)
|
3,698
|
(20,011
|
)
|
||||||
Net
cash used in investing activities
|
(58,779
|
)
|
(44,359
|
)
|
3,698
|
(99,440
|
)
|
||||||
Cash
flows from financing activities:
|
|||||||||||||
Note
payable related party
|
-
|
1,700,000
|
611,243
|
2,311,243
|
|||||||||
Contributed
capital from equity investors
|
850,000
|
1,150,000
|
-
|
2,000,000
|
|||||||||
Net
cash provided by financing activities
|
850,000
|
2,850,000
|
611,243
|
4,311,243
|
|||||||||
Net
increase (decrease) in cash
|
165,413
|
90,934
|
(107,215
|
)
|
149,132
|
||||||||
Cash
at beginning of period
|
-
|
165,413
|
256,347
|
-
|
|||||||||
Cash
at end of period
|
$
|
165,413
|
$
|
256,347
|
$
|
149,132
|
$
|
149,132
|
|||||
Supplemental
Disclosure of Cash Flow Information
|
|||||||||||||
Cash
paid during the year for:
|
|||||||||||||
Interest
|
$
|
-
|
$
|
-
|
$
|
-
|
$
|
-
|
|||||
Income
taxes
|
$
|
-
|
$
|
-
|
$
|
-
|
$
|
-
|
|||||
Non-cash
investing and financing activities:
|
|||||||||||||
Common
stock issued in merger
|
$
|
-
|
$
|
150,000
|
$
|
-
|
$
|
150,000
|
|||||
Costs
of merger recorded as
|
|||||||||||||
reduction
in paid in capital
|
$
|
-
|
$
|
(150,000
|
)
|
$
|
-
|
$
|
(150,000
|
)
|
March
31, 2005
|
June
30, 2005
|
||||||
Office
and computer equipment
|
$
|
53,082
|
$
|
53,082
|
|||
Computer
software
|
26,308
|
26,308
|
|||||
79,390
|
79,390
|
||||||
Less
accumulated depreciation
|
(29,529
|
)
|
(36,144
|
)
|
|||
$
|
49,862
|
$
|
43,246
|
March
31, 2005
|
June
30, 2005
|
||||||
Executive
relocation and legal
|
$
|
85,472
|
$
|
85,472
|
|||
Audit
|
40,000
|
40,000
|
|||||
Accrued
vacation
|
35,285
|
47,443
|
|||||
Deferred
Wages
|
-
|
36,720
|
|||||
Russian
programming costs
|
17,627
|
18,392
|
|||||
Consulting
|
14,000
|
14,000
|
|||||
Travel
and lodging
|
9,000
|
19,000
|
|||||
Miscellaneous
|
20,188
|
15,000
|
|||||
$
|
221,572
|
$
|
276,027
|
||||
Exercisbale
at
|
Exercise
|
|||||||||
Granted
|
March
31, 2005
|
Price
|
||||||||
Options
granted at or above fair value
|
||||||||||
Grants
under the Plan dated:
|
||||||||||
January
18, 2005
|
2,000,000
|
388,885
|
$
|
0.20
|
||||||
January
25, 2005
|
1,000,000
|
-
|
$
|
0.20
|
||||||
January
25, 2005
|
1,825,000
|
228,125
|
$
|
0.10
|
||||||
Total
grants under the Plan
|
4,825,000
|
617,010
|
||||||||
Grants
not under the Plan dated January 18, 2005
|
1,500,000
|
-
|
$
|
0.50
|
||||||
Total
grants
|
6,325,000
|
617,010
|
||||||||
Weighted
average expected life in years
|
10
|
Dividend
per share
|
none
|
Volatility
|
0%
|
Risk
free interest rate
|
4.0%
|
2005
|
||||
Current
Federal income taxes
|
$
|
-
|
||
Deferred
income tax benefit
|
(1,045,000
|
)
|
||
Change
in valuation allowance
|
1,045,000
|
|||
Total
income tax provision
|
$
|
-
|
Net
operating loss carryforwards
|
$
|
1,032,000
|
||
Accrued
vacation pay
|
13,000
|
|||
1,045,000
|
||||
Valuation
allowance for deferred tax assets
|
(1,045,000
|
)
|
||
Net
deferred tax asset
|
$
|
-
|
before
income taxes
|
34.0
|
%
|
||
Non
deductible items - registration costs
|
-5.9
|
%
|
||
State
income tax, net of federal tax benefit
|
3.6
|
%
|
||
Increase
in valuation allowance
|
-31.7
|
%
|
||
Total
income tax provision
|
0.0
|
%
|
2006
|
$
|
59,000
|
||
2007
|
62,000
|
|||
2008
|
59,000
|
|||
$
|
180,000
|